Oncocyte Corp
OCX
Revenue
104.00k
▼-72.00k▼-40.91%
3 Months ChangeAssets
74.72M
▲3.75M▲5.28%
3 Months ChangeLiabilities
52.02M
▼-2.04M▼-3.77%
3 Months ChangeFree Cash Flow
-3.85M
▲10.98M▲74.03%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-15
Form 8-K
ID: 0001493152-24-041133
2024-10-03
Form 8-K
ID: 0001493152-24-039269
2024-08-09
Form 8-K
ID: 0001493152-24-030865
2024-08-08
Form 10-Q
ID: 0001493152-24-030793
2024-08-08
Form 8-K
ID: 0001493152-24-030771
2024-07-12
Form 8-K
ID: 0001493152-24-027086
2024-07-05
Form 8-K
ID: 0001493152-24-026335
2024-06-17
Form 8-K
ID: 0001493152-24-024108
2024-05-31
Form 8-K
ID: 0001493152-24-022193
2024-05-23
Form 8-K
ID: 0001493152-24-021144